# Curegen Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curegen-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Taizhou, China
- Total disclosed funding: $8.9M
- Latest round: Series C (Sep 9, 2020)
- Investors on record: 7

## About

Based in Taizhou, China and established in 2010, Curegen Pharmaceuticals,Inc. operates as a pharmaceutical company which focuses on developing new drugs used in surgery and cancer treatment.

The company is mainly engaged in the research and development of new drugs, new drug delivery technologies and the improvement of generic drugs. The company's main drugs include general and anti-tumor APIs, sterile lyophilized preparations, solid preparations and small volume injections.

## Funding rounds

- Series C, Sep 9, 2020, $8.9M — Addor Capital, China Capital Management, Haisheng Investment Management Co.Ltd, Jiangsu Province
- Series B, Jan 1, 2019 — New Vision Ventures
- Series A, Mar 1, 2016 — CASH Capital, AnlongMed Investment, Taizhou Huajian Venture Capital

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series A
- AnlongMed Investment — Series A
- Taizhou Huajian Venture Capital — Series A
- New Vision Ventures (https://capitalatlas.ai/funds/new-vision-ventures) — Series B
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series C
- China Capital Management (https://capitalatlas.ai/funds/china-capital-management) — Series C
- Haisheng Investment Management Co.Ltd, Jiangsu Province — Series C